Frontiers in Microbiology (Aug 2016)

A flow cytometric and computational approaches to carbapenems affinity to the different types of carbapenemases

  • Cidália Pina-Vaz,
  • Cidália Pina-Vaz,
  • Cidália Pina-Vaz,
  • Ana Pinto Silva,
  • Ana Pinto Silva,
  • Isabel Faria-Ramos,
  • Isabel Faria-Ramos,
  • Rita Teixeira-Santos,
  • Daniel Moura,
  • Tatiana Freitas Vieira,
  • Sérgio Filipe Sousa,
  • Sofia Costa-de-Oliveira,
  • Sofia Costa-de-Oliveira,
  • Rafael Cantón,
  • Acácio Rodrigues,
  • Acácio Rodrigues

DOI
https://doi.org/10.3389/fmicb.2016.01259
Journal volume & issue
Vol. 7

Abstract

Read online

The synergy of carbapenem combinations regarding Enterobacteriaceae producing different types of carbapenemases was study through different approaches: flow cytometry and computa-tional analysis. Ten well characterized Enterobacteriaceae (KPC, verona integron-encoded metallo-β-lactamases –VIM and OXA-48-like enzymes) were selected for the study. The cells were incubated with a combination of ertapenem with imipenem, meropenem or doripenem and killing kinetic curves performed with and without reinforments of the drugs. A cephalosporin was also used in combination with ertapenem. A flow cytometric assay with DiBAC4-(3), a membrane potential dye, was developed in order to evaluate the cellular lesion after 2 h incuba-tion. A chemical computational study was performed to understand the affinity of the different drugs to the different types of enzymes. Flow cytometric analysis and time-kill assays showed a synergic effect against KPC and OXA-48 producing-bacteria with all combinations; only ertapenem with imipenem was synergic against VIM producing-bacteria. A bactericidal effect was observed in OXA-48-like enzymes. Ceftazidime plus ertapenem was synergic against ESBL-negative KPC producing-bacteria. Ertapenem had the highest affinity for those enzymes according to chemical computational study. The synergic effect between ertapenem and others carbapenems against different carbapenemase-producing bacteria, representing a therapeutic choice, was described for the first time. Easier and faster laboratorial methods for car-bapenemase characterization are urgently needed. The design of an ertapenem derivative with similar affinity to carbapenemases but exhibiting more stable bonds was demonstrated as highly desirable.

Keywords